Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Ovzon: Record-high sales, margins and FCF - ABG

Ovzon

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Sales +113% y-o-y on recent orders; 0%/-6% vs. ABG/cons* EBIT was +13% vs. ABG and +7% vs. cons, driven by higher GMs* Strong Q3 FCF - expect cons to make small revisionsQ3 resultsSales SEK 202m (0% vs ABGSCe 203m and -6% vs cons 216m), adj. EBIT 54m (13% vs ABG 48m and 7% vs cons 51m). As expected, NWC normalised following the depressed levels in Q2 (driven by payments from the FMV contract), resulting in FCF of SEK 194m (vs. SEK -41m in Q3'24). This resulted in both sales, margins and FCF reached record-high levels. Net debt totaled SEK 326m by end-of-Q3. The order book was robust at SEK 1.0bn by end-of-Q3 whereas the FMV order extends to 2027.Q3 thoughtsFollowing the SEK 1bn order from the Swedish FMV, Ovzon achieved a significant breakthrough in Q2, and this momentum continued in Q3. Sales improved markedly (+113% y-o-y) and while the EBIT margin was 27% (vs. -24% in Q3'24). On revenue streams, SATCOM and terminal sales met our expectations, comprising 80% and 20% of net sales, respectively. Nonetheless, margins were better than expected, driven by higher gross margins while opex was above our forecast. On the outlook, Ovzon highlights a growing global demand. There was no specific news regarding the situation in the US beyond the statement that 'The US market remains important and a special focus area for us' - we continue to expect it to rebound in 2026, albeit visibility remains blurred. Meanwhile, activity in Europe remains high.Estimate changesAt a first glance, we expect consensus to make small revisions to '25e-'26e EBIT. The stock is trading at 34x-14x '25e-'26e EV/EBIT on our unrevised estimates. There is a conference call 10.00 CET.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.